Management of hypothyroidism in adults

BMJ

Volumn 337, Issue 7664, 2008, Pages 284-289

  Vaidya, Bijay ^a,b   Pearce, Simon H S ^c  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; AMIODARONE; ARMOUR THYROID; CALCIUM SALT; CARBAMAZEPINE; CARBIMAZOLE; COLESTYRAMINE; FERROUS SULFATE; INTERFERON; IODINE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; PHENOBARBITAL; PHENYTOIN; PORCINE THYROID EXTRACT; PROPYLTHIOURACIL; RADIOACTIVE IODINE; RIFAMPICIN; SUNITINIB; THALIDOMIDE; THIAMAZOLE; THYROID HORMONE; UNCLASSIFIED DRUG;

AUTOIMMUNE THYROIDITIS; BIOSYNTHESIS; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONGENITAL HYPOTHYROIDISM; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; DRUG CLEARANCE; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; GOITER; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; HYPOTHYROIDISM; IATROGENIC DISEASE; INCIDENCE; IODINE DEFICIENCY; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; LIOTHYRONINE BLOOD LEVEL; PATIENT MONITORING; POSTPARTUM THYROIDITIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SCREENING; SUBACUTE THYROIDITIS; THYROID HORMONE BLOOD LEVEL; THYROIDECTOMY; THYROXINE BLOOD LEVEL; TREATMENT CONTRAINDICATION; TURNER SYNDROME;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MYOCARDIAL INFARCTION; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES; REFERRAL AND CONSULTATION; THYROTROPIN; THYROXINE;

EID: 49149121730     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a801     Document Type: Review

References (35)

1. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43:55-68.
2. Information Centre for Health and Social Care. Prescription cost analysis 2006. www.ic.nhs.uk/statistics-and-data-collections/primary-care/prescriptions/ prescription-cost-analysis-2006.
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
4. Parte JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993;43:107-9.
5. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57:577-85.
6. Harris KB, Pass KA. Increase in congenital hypothyroidism in New York state and in the United States. Mol Genet Metab 2007;91:268-77.
7. Adriaanse R, Romijn JA, Endert E, Wiersinga WM. The nocturnal thyroid-stimulating hormone surge is absent in overt, present in mild primary and equivocal in central hypothyroidism. Acta Endocrinol (Copenh) 1992;126:206-12.
8. UK Guidelines for the use of thyroid function tests. Association of Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation. www.british-thyroid-association.or_/TFT_guideline_final_version_July_2006.pdf.
9. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38.
10. Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, et al. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab 2007;92:608-11.
11. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008;148:832-45.
12. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta-analysis. J Clin Endocrinol Metab 2008. http://jcem.endojournals.org/cgi/rapidpdf/jc.2008-0167v1.
13. Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007(3):CD003419.
14. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-9.
15. Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJ, McMahon AD, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001;323:891-5.
16. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005;165:1714-20.
17. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987;316:764-70.
18. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001;344:1743-9.
19. Raftopoulos Y, Gagne DJ, Papasavas P, Hayetian F, Maurer J, Bononi P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14:509-13.
20. Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983;75:206-9.
21. Demers L, Spencer CE. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. National Academy of Clinical Biochemistry, 2002. www.aacc.org/SiteCollectionDocuments/NACB/LMPG/ thyroid/ThyroidFullVersionwithCover.pdf.
22. Can D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 1988;28:325-33.
23. Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab 2006;91:2624-30.
24. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996;81:4278-89.
25. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
26. Grebe SK, Cooke RR, Ford HC, Fagerstrom JN, Cordwell DP, Lever NA, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 1997;82:870-5.
27. McDermott JH, Coss A, Walsh CH. Celiac disease presenting as resistant hypothyroidism. Thyroid 2005;15:386-8.
28. Checchi S, Montanaro A, Pasqui L, Ciuoli C, De Palo V, Chiappetta MC, et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 2008;93:465-9.
29. Murray JS, Jayarajasingh R, Perros P. Lesson of the week: deterioration of symptoms after start of thyroid hormone replacement. BMJ 2001;323:332-3.
30. Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf) 2007;66:43-8.
31. Bernstein R, Muller C, Midtbo K, Smith G, Haug E, Hertzenberg L. Silent myocardial ischemia in hypothyroidism. Thyroid 1995;5:443-7.
32. Glinoer D, Abalovich M. Unresolved questions in managing hypothyroidism during pregnancy. BMJ 2007;335:300-2.
33. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004;140:125-7.
34. Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008;299:769-77.
35. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006;91:2592-9.